Learn More
Apexbio Technology LLC VX-765 273404-37-8 100mg

Supplier: Apexbio Technology LLC A8238100

VX-765 (CAS 273404-37-8) is an orally bioavailable prodrug of VRT-043198 a selective inhibitor targeting caspase-1 (also known as IL-1 converting enzyme ICE) Caspase-1 plays a pivotal role in processing pro-inflammatory cytokines specifically converting inactive precursors of IL-1 and IL-18 into bioactive forms VX-765 downstream metabolite VRT-043198 selectively reduces the secretion of IL-1 and IL-18 in stimulated human peripheral blood mononuclear cells without affecting release of other cytokines such as IL-6 or TNF- Preclinical studies demonstrate VX-765 activity in mouse models of arthritis dermatitis and HIV-associated CD4 T-cell death indicating utility in inflammatory and immunological research
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.